Non-linear elimination processes of theophylline

Area of Science:

• Pharmacology
• Clinical Pharmacokinetics
• Drug Metabolism

Background:

• Theophylline is a widely used bronchodilator with a narrow therapeutic index.
• Understanding its pharmacokinetic profile, including dose-dependent effects and metabolite excretion, is crucial for safe and effective use.

Purpose of the Study:

• To investigate the pharmacokinetic behavior of theophylline after intravenous and oral administration in healthy subjects.
• To characterize the elimination pathways and metabolite profiles of theophylline.

Main Methods:

• Four healthy subjects received intravenous and oral doses of theophylline.
• Plasma and urine samples were collected to determine theophylline and its metabolites (1,3-dimethyluric acid, 1-methyluric acid, 3-methylxanthine, 3-methyluric acid).
• Pharmacokinetic parameters, including clearance and excretion rates, were calculated.

Main Results:

• Theophylline plasma concentration-time curves followed linear pharmacokinetics, but total clearance decreased with increased doses.
• Renal clearance of theophylline significantly decreased over time post-administration.
• 1,3-dimethyluric acid was identified as the major metabolite with constant renal clearance, suggesting potential zero-order formation at high concentrations.
• Excretion rates of other metabolites (1-methyluric acid, 3-methylxanthine) were also characterized.

Conclusions:

• Theophylline exhibits dose-dependent clearance and reduced renal clearance over time in healthy individuals.
• The metabolism and renal excretion of theophylline and its primary metabolite, 1,3-dimethyluric acid, are significant elimination pathways.
• Findings highlight the importance of considering dose adjustments and individual variability in theophylline therapy.